_Anthony_Brown_Alamy.jpg?#)
Makary’s FDA Has Options In Industry Fight Over Weight Loss Drugs
Americans pay far more for GLP-1 drugs than citizens in other wealthy countries. If Dr. Makary, the new FDA Commissioner, wants to change this, he has several options.
Americans pay far more for GLP-1 drugs than citizens in other wealthy countries. If Dr. Makary, the new FDA Commissioner, wants to change this, he has several options.
